Patients using metformin and DDP-4i experienced a slower cognitive decline over time compared to non-users of these drugs. In contrast, patients using insulin and SUs showed a larger point-wise decrement in MMSE score with annual intervals compared to DDP-4i users. The gene discussed is INS; the disease is Mental deterioration.